Prevalence of prescribing topical corticosteroids to patients with lichen sclerosus following surgery for vulvar cancer: a survey among gynaecologic oncologists in The Netherlands

References

• ACOG, American College of Obstetricians and Gynecologists. 2020. Diagnosis and management of vulvar skin disorders: ACOG Practice Bulletin, Number 224. Obstetrics & Gynecology, 136, e1–e14.
   PubMed Web of Science ®Google Scholar
• Bigby, S.M., et al., 2016. The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges. International Journal of Gynecological Pathology, 35 (6), 574–584.
   PubMed Web of Science ®Google Scholar
• Bleeker, M.C., et al., 2016. Lichen Sclerosus: incidence and risk of Vulvar Squamous cell carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 25 (8), 1224–1230.
   PubMed Web of Science ®Google Scholar
• Chin, S., et al., 2020. Association of topical corticosteroids with reduced vulvar squamous cell carcinoma recurrence in patients with vulvar Lichen Sclerosus. JAMA Dermatology, 156 (7), 813–814.
   PubMed Web of Science ®Google Scholar
• Cohen, P.A., et al., 2019. Clinical and molecular classification of vulvar squamous pre-cancers. International Journal of Gynecological Cancer, 29 (4), 821–828.
   PubMed Web of Science ®Google Scholar
• Fergus, K.B., et al., 2020. Pathophysiology, clinical manifestations, and treatment of Lichen Sclerosus: a systematic review. Urology, 135, 11–19.
   PubMed Web of Science ®Google Scholar
• Gallio, N., et al., 2023. Differentiated Vulvar Intraepithelial Neoplasia: three decades’ experience of a referral center. 14th Congress of European College for the Study of Vulval Disease (ECSVD), Helsinki, Finland.
   Google Scholar
• IKNL, Integraal Kankercentrum Nederland. 2018. Werkgroep oncologische gynaecologie. Utrecht, The Netherlands: Landelijke richtlijn Vulvacarcinoom.
   Google Scholar
• Kirtschig, G., et al., 2015. Evidence-based (S3) guideline on (anogenital) Lichen sclerosus. Journal of the European Academy of Dermatology and Venereology, 29 (10), e1-43–43.
   PubMed Web of Science ®Google Scholar
• Lee, A., Bradford, J. and Fischer, G., 2015. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatology, 151 (10), 1061–1067.
   PubMed Web of Science ®Google Scholar
• Leis, M., et al., 2022. Risk of vulvar squamous cell carcinoma in Lichen Sclerosus and Lichen Planus: a systematic review. Journal of Obstetrics and Gynaecology Canada, 44 (2), 182–192.
   PubMed Web of Science ®Google Scholar
• Lewis, F.M., et al., 2018. British association of dermatologists guidelines for the management of lichen sclerosus, 2018. The British Journal of Dermatology, 178 (4), 839–853.
   PubMed Web of Science ®Google Scholar
• Mautz, T.T., Krapf, J.M. and Goldstein, A.T., 2022. Topical corticosteroids in the treatment of vulvar Lichen Sclerosus: a review of pharmacokinetics and recommended dosing frequencies. Sexual Medicine Reviews, 10 (1), 42–52.
   PubMed Web of Science ®Google Scholar
• Morrison, J., et al., 2020. British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: recommendations for practice. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 252, 502–525.
   PubMed Web of Science ®Google Scholar
• Nooij, L.S., et al., 2017. Genomic characterization of vulvar (Pre)cancers identifies distinct molecular subtypes with prognostic significance. Clinical Cancer Research, 23 (22), 6781–6789.
   PubMed Web of Science ®Google Scholar
• NVDV, Nederlandse Vereniging voor Dermatologie en Venereologie. 2021. Richtlijn Lichen sclerosus. Utrecht, The Netherlands: Richtlijnendatabase.
   Google Scholar
• Oonk, M.H.M., et al., 2017. European society of gynaecological oncology guidelines for the management of patients with vulvar cancer. International Journal of Gynecological Cancer, 27 (4), 832–837.
   PubMed Web of Science ®Google Scholar
• Pounds, R., et al., 2018. A survey on the use of topical steroids in patients treated for lichen sclerosus-associated vulval squamous cell carcinoma. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, 38 (2), 265–269.
   PubMedGoogle Scholar
• RCOG, Royal College of Obstetricians and Gynaecologists. 2014. Guidelines for the diagnosis and management of vulval carcinoma. England: Royal College of Obstetricians and Gynaecologists
   Google Scholar
• Regauer, S., Eberz, B. and Reich, O., 2011. Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women. Gynecologic Oncology, 123 (2), 289–294.
   PubMed Web of Science ®Google Scholar
• Renaud-Vilmer, C., et al., 2004. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Archives of Dermatology, 140 (6), 709–712.
   PubMedGoogle Scholar
• Saito, T., et al., 2018. Japan society of gynecologic oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. International Journal of Clinical Oncology, 23 (2), 201–234.
   PubMed Web of Science ®Google Scholar
• Schnürch, H. G., et al., 2016. Diagnosis, therapy and follow-up care of vulvar cancer and its precursors. Guideline of the DGGG and DKG (S2k-level, AWMF registry number 015/059, November 2015. Geburtshilfe Und Frauenheilkunde, 76 (10), 1035–1049.,
   PubMed Web of Science ®Google Scholar
• Singh, N. and Gilks, C.B., 2020. Vulval squamous cell carcinoma and its precursors. Histopathology, 76 (1), 128–138.
   PubMed Web of Science ®Google Scholar
• Spekreijse, J.J., et al., 2020. The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: a systematic review. Gynecologic Oncology, 157 (3), 671–677.
   PubMed Web of Science ®Google Scholar
• Swarts, D.R.A., et al., 2018. Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis. Cancer Medicine, 7 (9), 4542–4553.
   PubMed Web of Science ®Google Scholar
• Te Grootenhuis, N.C., et al., 2019. Margin status revisited in vulvar squamous cell carcinoma. Gynecologic Oncology, 154 (2), 266–275.
   PubMed Web of Science ®Google Scholar
• Van De Nieuwenhof, H.P., et al., 2010. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. Journal of Psychosomatic Obstetrics and Gynaecology, 31 (4), 279–284.
   PubMed Web of Science ®Google Scholar
• Van De Nieuwenhof, H.P., Van Der Avoort, I.A. and De Hullu, J.A., 2008. Review of squamous premalignant vulvar lesions. Critical Reviews in Oncology/Hematology, 68 (2), 131–156.
   PubMed Web of Science ®Google Scholar
• Vieira-Baptista, P., et al., 2022. Risk of development of vulvar cancer in women with Lichen Sclerosus or Lichen Planus: a systematic review. Journal of Lower Genital Tract Disease, 26 (3), 250–257.
   PubMed Web of Science ®Google Scholar
• Virgili, A., et al., 2013. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. The British Journal of Dermatology, 168 (6), 1316–1324.
   PubMed Web of Science ®Google Scholar
• WHO, World Health Organization. 2020., World health organization classification of tumours, female genital tumours. 5th ed. Lyon, France: IARC Press.
   Google Scholar
• Wijaya, M., et al., 2021. Quality of life in vulvar Lichen Sclerosus patients treated with long-term topical corticosteroids. Journal of Lower Genital Tract Disease, 25 (2), 158–165.
   PubMed Web of Science ®Google Scholar
• Yap, J.K., et al., 2016. Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecologic Oncology, 142 (3), 420–426.
   PubMed Web of Science ®Google Scholar
• Yeon, J., et al., 2021. Vulval lichen sclerosus: an Australasian management consensus. The Australasian Journal of Dermatology, 62 (3), 292–299.
   PubMed Web of Science ®Google Scholar